Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea
· Delayed Price · Currency is KRW 5,500.00
-340.00 (-5.82%)
At close: Apr 28, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 41.64 billion as of April 28, 2026. Its market cap has decreased by -40.73% in one year.
Market Cap
41.64B
Enterprise Value
43.71B
Revenue
381.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,500.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 41.64B, a decrease of -64.86%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 41.64B | 48.91% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEKICS CO., | 44.79B |
| UXN Co., Ltd. | 35.18B |
| Genoray | 57.21B |
| CU Medical Systems | 33.17B |
| DRGEM | 62.32B |
| JPI Healthcare | 63.15B |
| Hironic | 74.74B |
| Neofect | 78.72B |